Novartis
NVS
#59
Rank
NZ$434.42 B
Marketcap
NZ$226.41
Share price
0.14%
Change (1 day)
36.07%
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

Novartis (NVS) - Total assets

Total assets on the balance sheet as of September 2025 : NZ$185.15 Billion

According to Novartis's latest financial reports the company's total assets are NZ$185.15 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Novartis - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31NZ$181.29 B14.71%
2023-12-31NZ$158.04 B-14.57%
2022-12-31NZ$184.99 B-4.12%
2021-12-31NZ$192.95 B8.96%
2020-12-31NZ$177.09 B0.76%
2019-12-31NZ$175.75 B-19.01%
2018-12-31NZ$217.00 B15.81%
2017-12-31NZ$187.38 B-0.25%
2016-12-31NZ$187.85 B-2.27%
2015-12-31NZ$192.21 B20.11%
2014-12-31NZ$160.03 B4.16%
2013-12-31NZ$153.63 B1.77%
2012-12-31NZ$150.96 B0.28%
2011-12-31NZ$150.54 B-5.82%
2010-12-31NZ$159.84 B21.56%
2009-12-31NZ$131.49 B-2.54%
2008-12-31NZ$134.92 B36.98%
2007-12-31NZ$98.50 B2.04%
2006-12-31NZ$96.53 B14.29%
2005-12-31NZ$84.46 B14.83%
2004-12-31NZ$73.55 B-3.04%
2003-12-31NZ$75.86 B-11.82%
2002-12-31NZ$86.03 B-11.36%
2001-12-31NZ$97.06 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Merck
MRK
NZ$223.57 B 20.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$360.22 B 94.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$332.76 B 79.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$262.88 B 41.98%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
NZ$142.31 B-23.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$68.78 B-62.85%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bristol-Myers Squibb
BMY
NZ$167.21 B-9.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$145.27 B-21.54%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$197.52 B 6.68%๐Ÿ‡ฌ๐Ÿ‡ง UK